SMN1 and invasive carcinoma: Assessment of the expression and localization of smooth muscle actin (SMA), a sensitive and specific myoepithelial marker commonly employed to facilitate the identification of basal-like tumors [35, 36], revealed a prominent distribution of SMA within the invasive carcinoma tissue of CA1d tumors (Figure 2F).